LGALS3 and COVID-19: Although elevated markers of complement and endothelial activation as well as elevated Galectin-3 concentrations were demonstrated in COVID-19 patients, most studies compared cases with healthy controls, and therefore may overestimate the specificity of the innate immune response upon SARS-CoV-2 infection.